Morepen Laboratories Limited

NSE:MOREPENLAB.NS

83.79 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 521.166-578.436232.863-563.055216.658-406.489110.836-459.706158.026-515.515208.404-678.942413.869-680.714307.372-388.804136.391-282.85931.828-324.97895.951-155.141155.141-59.33957.161-70.047
Short Term Investments 495.531,156.872410.8551,126.11401.524812.978356.203919.412352.3091,031.03312.9381,357.884270.8931,361.428373.349777.6080565.718256.181649.9560.225310.282142.82118.6782.178140.094
Cash and Short Term Investments 521.166578.436643.718563.055618.182406.489467.039459.706158.026515.515521.342678.942413.869680.714680.721388.804136.391282.859288.009324.97896.176155.141297.96159.33959.33970.047
Net Receivables 3,251.62402,847.28102,635.20702,551.11704,426.44502,245.87302,093.47902,113.87701,376.80501,707.13701,838.65801,127.22901,636.1510
Inventory 2,485.94202,308.26102,288.86302,413.06302,758.54102,108.82701,753.25701,300.43501,384.75701,022.5720942.0160809.7860768.8690
Other Current Assets 2,631.70802,356.00302,019.39501,579.4460-0.00101,850.03801,007.3050866.88602,200.6170762.8120117.8340436.41706.9270
Total Current Assets 8,890.44578.4368,155.263563.0557,561.647406.4897,010.665459.7067,343.011515.5156,726.08678.9425,267.91680.7144,961.919388.8043,721.765282.8593,780.53324.9782,994.684155.1412,671.39359.3392,471.28670.047
Non-Current Assets:
Property, Plant & Equipment, Net 2,376.55902,132.09501,840.12701,690.65401,607.92901,452.1301,312.41501,265.27401,340.89401,406.73901,473.67101,621.40101,723.9670
Goodwill 744.7420744.7420744.7420744.7420744.7420744.7420744.7420745.4940744.7420744.7590744.7980743.6920744.8540
Intangible Assets 196.6820197.3980254.9860291.4010309.3380314.6960210.188053.242080.6160110.5940146.1590123.7230176.6770
Goodwill and Intangible Assets 941.4240942.140999.72801,036.14301,054.0801,059.4380954.930798.7360825.3580855.3530890.9570867.4150921.5310
Long Term Investments 84.7840-347.0780-337.7470-298.16300.572010.850-260.0430-362.499010.85000000000
Tax Assets 196.6820411.350402.0190356.775091.84100.6050268.9640374.0290-10.85000000000
Other Non-Current Assets 442.162-578.436644.047-563.055639.177-406.489725.776-459.706603.094-515.5151,130.643-678.9421,037.284-680.714829.354-388.804746.622-282.859826.563-324.978792.462-155.141819.757-59.339741.28-70.047
Total Non-Current Assets 4,041.611-578.4363,782.554-563.0553,543.304-406.4893,511.185-459.7063,357.516-515.5153,653.666-678.9423,313.55-680.7142,904.894-388.8042,912.874-282.8593,088.655-324.9783,157.09-155.1413,308.573-59.3393,386.778-70.047
Total Assets 12,932.051011,937.817011,104.951010,521.85010,700.527010,379.74608,581.4607,866.81306,634.63906,869.18506,151.77405,979.96605,858.0640
Liabilities & Equity:
Current Liabilities:
Account Payables 2,950.27502,438.66202,268.79301,626.09502,581.15602,778.94202,088.48902,060.81401,723.04301,674.69501,681.50201,676.85401,748.8450
Short Term Debt 256.3520264.8790242.3060216.7140172.4790115.3280162.1740152.3130125.4350142.6980101.14701,556.6440116.170
Tax Payables 131.83500016.45800050.64500028.60600014.77100051.3700010.7470
Deferred Revenue 00789.0750663.6750613.99101,805.14801,836.453028.60601,818.58301,622.45801,566.54801,565.550-1,556.64401,492.70
Other Current Liabilities 813.8190169.443036.8570348.01505.7860418.93401,758.7310157.809043.50510.204043.501,663.516043.4990
Total Current Liabilities 4,020.44603,662.05903,211.63102,804.81504,564.56905,149.65704,03804,189.51903,514.43603,894.14503,391.69903,340.3703,401.2140
Non-Current Liabilities:
Long Term Debt 33.64012.67509.335011.4013.21106.48708.28306.94709.246015.578018.292024.712029.4730
Deferred Revenue Non-Current -0000341.9830328.5380330.12700000000000000000
Deferred Tax Liabilities Non-Current 22.495026.86026.86024.826024.82600000000000000000
Other Non-Current Liabilities 383.2080350.8850-9.3350-11.40-13.2110305.7680292.2720364.8940274.980328.2790215.4860259.4550172.5030
Total Non-Current Liabilities 439.3430390.420368.8430353.3640354.9530312.2550300.5550371.8410284.2260343.8570233.7780284.1670201.9760
Total Liabilities 4,459.78904,052.47903,580.47403,158.17904,919.52205,461.91204,338.55504,561.3603,798.66204,238.00203,625.47703,624.53703,603.190
Equity:
Preferred Stock 00006,620.2770004,787.00500000000000000000
Common Stock 1,022.27101,022.27101,022.27101,022.2710955.5860899.5860899.5860899.5860899.5860899.5860899.5860899.5860899.5860
Retained Earnings 2,861.7190001,900.120001,513.368000546.542000-424.317000-760.109000-1,048.6020
Accumulated Other Comprehensive Income/Loss 7,449.9917,889.9486,867.6777,529.081908.8047,368.2836,346.0125,785.612998.6074,922.434,022.8444,247.4981,127.3193,310.0912,410.5052,840.611-4,955.2912,635.8171,736.2312,530.928-6,178.6212,359.9751,460.3892,259.416-7,060.0581,962.616
Other Total Stockholders Equity -2,861.719-4.610-4.604-2,922.391-4.6120-4.607-2,468.954-4.5960-4.5931,674.051-4.6380-4.6347,320.633-4.6340-4.6318,570.072-4.5460-4.5429,468.49-6.337
Total Shareholders Equity 8,472.2627,885.3387,889.9487,524.4777,529.0817,363.6717,368.2835,781.0055,785.6124,917.8344,922.434,242.9054,247.4983,305.4533,310.0912,835.9772,840.6112,631.1832,635.8172,526.2972,530.9282,355.4292,359.9752,254.8742,259.4161,956.279
Total Equity 8,472.2627,885.3387,885.3387,524.4777,524.4777,363.6717,363.6715,781.0055,781.0054,917.8344,917.8344,242.9054,242.9053,305.4533,305.4532,835.9772,835.9772,631.1832,631.1832,526.2972,526.2972,355.4292,355.4292,254.8742,254.8741,956.279
Total Liabilities & Shareholders Equity 12,932.0517,885.33811,937.8177,524.47711,104.9517,363.67110,521.855,781.00510,700.5274,917.83410,379.7464,242.9058,581.463,305.4537,866.8132,835.9776,634.6392,631.1836,869.1852,526.2976,151.7742,355.4295,979.9662,254.8745,858.0641,956.279